These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study]. Tsushima T, Nasu Y, Abeki N, Noda M, Saika T, Ohmori H, Kobashi K, Ozaki Y, Matsumura Y, Tanahashi T. Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170 [Abstract] [Full Text] [Related]
3. [Prophylactic intravesical instillation therapy with adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer]. Ozaki Y, Tsushima T, Nasu Y, Akagi T, Obama T, Matsumura Y, Ohmori H. Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1493-500. PubMed ID: 3100850 [No Abstract] [Full Text] [Related]
4. Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer. Jauhiainen K, Alfthan O. Br J Urol; 1987 Jul; 60(1):54-9. PubMed ID: 3113524 [Abstract] [Full Text] [Related]
6. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence]. Yasumoto R, Asakawa M, Yoshihara H, Sakamoto W, Iseki T, Nakatani T, Wada S, Kishimoto T, Maekawa M, Nishio S. Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082 [Abstract] [Full Text] [Related]
7. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group. Naito S, Kotoh S, Omoto T, Osada Y, Sagiyama K, Iguchi A, Ariyoshi A, Hiratsuka Y, Kumazawa J. Cancer Chemother Pharmacol; 1998 Apr; 42(5):367-72. PubMed ID: 9771950 [Abstract] [Full Text] [Related]
9. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside]. Kinoshita N, Tochigi H, Yanagawa M, Yamakawa K, Sakurai M, Hioki T, Kawamura J. Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807 [Abstract] [Full Text] [Related]
10. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group. Togashi M, Shinohara N, Toyota K, Koyanagi T, Maru A, Fujieda J, Kawakura K, Nishida T, Ohashi N. Cancer Chemother Pharmacol; 1992 Mar; 30 Suppl():S21-5. PubMed ID: 1394811 [Abstract] [Full Text] [Related]
15. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder. Kurth KH, Bouffioux C, Sylvester R, de Pauw M. Prog Clin Biol Res; 1988 Mar; 269():525-37. PubMed ID: 3134663 [No Abstract] [Full Text] [Related]